New Horizons of Acute Myocardial Infarction: From the Korea Acute Myocardial Infarction Registry

Abstract

As the first nationwide Korean prospective multicenter data collection registry, the Korea Acute Myocardial Infarction Registry (KAMIR) launched in November 2005. Through a number of innovative approaches, KAMIR suggested new horizons about acute myocardial infarction (AMI) which contains unique features of Asian patients from baseline characteristics to treatment strategy. Obesity paradox was existed in Korean AMI patients, whereas no gender differences among them. KAMIR score suggested new risk stratifying method with increased convenience and an enhanced accuracy for the prediction of adverse outcomes. Standard loading dose of clopidogrel was enough for Asian AMI patients. Triple antiplatelet therapy with aspirin, clopidogrel and cilostazol could improve clinical outcomes than dual antiplatelet therapy with aspirin and clopidogrel. Statin improved clinical outcomes even in AMI patients with very low LDL-C levels. The rate of percutaneous coronary intervention was higher and door-to-balloon time was shorter than the previous reports. Zotarolimus eluting stents as the 2nd generation drug-eluting stent (DES) was not superior to the 1st generation DES, in contrast to the western AMI studies. KAMIR made a cornerstone in the study of Korean AMI and expected to be new standards of care for AMI with the renewal of KAMIR design to overcome its pitfalls.

The Contemporary Use of Angiography and Revascularization Among Patients With Non–ST‐Segment Elevation Myocardial Infarction in the United States Compared With South Korea

“…We evaluated the use of an invasive strategy and the profile of NSTEMI patients in the U.S. and South Korea by leveraging unique concurrent data from the Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With The Guidelines (ACTION Registry‐GWTG) and the Korea Acute Myocardial Infarction Registry (KAMIR)/Korea Working Group on Myocardial Infarction (KorMI) Registry …”

The Prognostic Value of the Left Ventricular Ejection Fraction Is Dependent upon the Severity of Mitral Regurgitation in Patients with Acute Myocardial Infarction

“…The 50 participating hospitals are capable of performing primary percutaneous coronary intervention (PCI). Details of the KAMIR have been published previously ( 2 , 12 , 13 ). A total of 15,097 patients with AMI who received echocardiography were registered in the KAMIR between January 2005 and July 2011.…”

Clinical Benefit of Statins in Korean Patients with Acute Myocardial Infarction: Experience of the Korea Acute Myocardial Infarction Registry

“…The Korea Acute Myocardial Infarction Registry (KAMIR) is the first nationwide, prospective, multicenter registry of Korean patients with AMI. [1][2][3] Since the KAMIR first began in November 2005, more than 75,250 patients have been enrolled, and 271 (The Science Citation Index: 250) papers have been published (as of March 2020). Moreover, published data from the KAMIR have revealed different characteristics from those of Western AMI registries regarding risk factors, interventional strategies, and clinical outcomes.…”